Related Experiment Videos
What's in a cardiomyocyte - And how do we make one through reprogramming?
Benjamin Keepers1, Jiandong Liu1, Li Qian1
1McAllister Heart Institute, Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.
Biochimica Et Biophysica Acta. Molecular Cell Research
|March 30, 2019
Summary
Cardiac reprogramming shows promise for treating heart disease by generating new heart cells. While these reprogrammed cells closely match textbook definitions, further research is needed to understand variations and optimize techniques.
Area of Science:
- Cardiovascular Biology
- Regenerative Medicine
- Cellular Reprogramming
Background:
- Cardiac reprogramming offers a novel therapeutic strategy for ischemic heart diseases.
- This field challenges fundamental concepts of cell fate and identity.
- Defining cardiomyocyte characteristics is crucial for evaluating reprogramming success.
Purpose of the Study:
- To review the history and modern definition of cardiomyocytes.
- To analyze screening approaches and factor combinations in cardiac reprogramming studies.
- To evaluate the evidence supporting the generation of de novo cardiomyocytes.
Main Methods:
- Historical review of cardiomyocyte research.
- Analysis of published cardiac reprogramming studies, including methodologies and factor combinations.
- Examination of evidence presented for successful cardiomyocyte generation.
- Discussion of molecular mechanisms underlying cardiac reprogramming.
Main Results:
- Cells generated through cardiac reprogramming largely align with the established definition of a cardiomyocyte.
- Variations exist across different study designs and their outcomes.
- The reasons for these observed differences between studies remain largely unexplained.
Conclusions:
- Cardiac reprogramming is advancing, with potential therapeutic applications for heart conditions.
- Generated cells closely resemble canonical cardiomyocytes, validating the approach.
- Further investigation into both reprogramming mechanisms and native cardiomyocyte biology is essential for progress.